Health and Human Services Secretary Robert F. Kennedy Jr.
Keep Reading →
June 13 - News
The Bureau of Labor Statistics stated on June 11 that consumer prices increased less than anticipated in May given that President Donald Trump's tariffs had not yet had a noticeable...
Keep Reading →
June 12 - Hedge Funds, News
On Friday, Mad Money host Jim Cramer shared his evolving view of Elon Musk’s company as he provided both praise and caution in light of recent developments involving Musk and...
Keep Reading →
June 11 - Hedge Funds, News
Madison Investments, an investment advisor, released its “Madison Sustainable Equity Strategy” first quarter 2025 investor letter.
Keep Reading →
June 11 - Hedge Fund Investor Letters, News
We came across a bullish thesis on Eli Lilly and Company (LLY) on Business Model Mastery’s Substack. In this article, we will summarize the bulls’ thesis on LLY.
Keep Reading →
June 9 - News, Stock Analysis
This target price adjustment aligns with investors shifting their focus towards the third quarter results of the SURPASS-CVOT trial.
Keep Reading →
June 5 - News
On Tuesday, Camurus (OTC:CAMRF) and Eli Lilly and Company (NYSE:LLY) entered into a collaboration and license agreement.
Keep Reading →
June 4 - News
In collaboration with Eli Lilly and Company (NYSE:LLY), a pharmaceutical company recognized globally for its innovative diabetes and metabolic therapies, Nxera Pharma has reached...
Keep Reading →
June 2 - News
On May 30, BMO Capital Markets reiterated its Outperform rating on Eli Lilly and Company (NYSE:LLY), setting a price target of $900 following the company’s announcement of a...
Keep Reading →
June 2 - News
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q1 2025 investor letter.
Keep Reading →
June 2 - Hedge Fund Investor Letters, News
We recently published a list of Did Jim Cramer Nail or Miss These 11 Stock Predictions? In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) ...
Keep Reading →
May 29 - News
During the most recent episode of Mad Money, which aired on Tuesday the 27th of May, Jim Cramer opened with a passionate defense of the artificial intelligence boom, warning viewers...
Keep Reading →
May 29 - Hedge Funds, News
We recently published a list of Jim Cramer Had These 21 Stocks on His Radar.
Keep Reading →
May 27 - News
Eli Lilly and Company (NYSE:LLY) is expanding its footprint into the non-opioid pain management market in pursuit of growth opportunities.
Keep Reading →
May 27 - News
Jim Cramer, host of Mad Money, pointed out on Friday that the markets just experienced their worst week since early April and highlighted a mix of pressures affecting investors...
Keep Reading →
May 27 - Hedge Funds, News
Eli Lilly and Company (NYSE:LLY) recently announced that Australia's Therapeutic Goods Administration (TGA) has approved Kisunla (donanemab) for marketing.
Keep Reading →
May 22 - News
On May 16, Eli Lilly and Company (NYSE:LLY) announced a partnership with Rznomics to develop RNA-based gene therapies for sensorineural hearing loss, with milestone payments exceeding...
Keep Reading →
May 17 - News
The U.S. stock market had one of the worst starts, at least the worst start to a presidency since 1928.
Keep Reading →
May 14 - Hedge Funds, News
On Monday's episode of Mad Money, Jim Cramer broke down the day’s market rally and argued in favor of staying invested, even in times of uncertainty.
Keep Reading →
May 13 - Hedge Funds, News
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
Keep Reading →
May 12 - Hedge Funds, Industries, News
Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive strategy.
Keep Reading →
May 10 - Dividend Stocks, Hedge Funds, News
We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on LLY.
Keep Reading →
May 7 - News, Stock Analysis
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Keep Reading →
May 3 - News, Transcripts
On April 29, Dan Ives of Wedbush Securities joined 'Power Lunch' on CNBC to discuss his outlook for the tech sector and expressed that tariffs aren't stopping the AI revolution...
Keep Reading →
April 30 - Hedge Funds, News
During the most recent episode of Mad Money, Jim Cramer revisited the recent turbulence in artificial intelligence stocks, three months after the emergence of DeepSeek, a Chinese...
Keep Reading →
April 30 - Hedge Funds, News
On Friday, Mad Money host Jim Cramer took a close look at what he called one of the most important stretches of the earnings season, which came alongside major economic developments...
Keep Reading →
April 29 - Hedge Funds, News
Dividend stocks are increasingly popular with both every day and billionaire investors.
Keep Reading →
April 27 - Dividend Stocks, Hedge Funds, News
The healthcare industry, an essential component of global well-being and economic resilience, is undergoing significant changes.
Keep Reading →
April 26 - Business, Hedge Funds, News
The markets have had two monster years with the S&P 500 index surging 24.73% and 24.01% in 2023 and 2024, respectively.
Keep Reading →
April 25 - Hedge Funds, News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed whether President Trump could fire the chairman of the Federal Reserve, Jerome Powell.
Keep Reading →
April 23 - News
Threats of an impending recession are looming over the stock market due to Trump's tariffs and macroeconomic uncertainty.
Keep Reading →
April 22 - Hedge Funds, News
Dividend-paying stocks have long benefited investors by delivering consistent and solid returns.
Keep Reading →
April 20 - Dividend Stocks, Hedge Funds, News
The US stock market experienced a turbulent first quarter of 2025, marked by increased volatility and negative returns across the major indices.
Keep Reading →
April 18 - Hedge Funds, News
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.
Keep Reading →
April 16 - Hedge Funds, News
Dividend-paying stocks have traditionally been seen as a solid foundation for investment portfolios, offering steady income and helping cushion the impact of market swings.
Keep Reading →
April 16 - Dividend Stocks, Hedge Funds, News
The US stock market is showing volatility after President Donald Trump's recent announcement of sweeping 10% tariffs on all US trading partners and higher tariffs on countries...
Keep Reading →
April 15 - Hedge Funds, News
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.
Keep Reading →
April 14 - Hedge Funds, News
Dividend stocks have trailed the broader market over the past two years, largely due to investors favoring AI-focused companies.
Keep Reading →
April 14 - Dividend Stocks, Hedge Funds, News
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer analyzed the extraordinary market turnaround following President Trump’s unexpected 90-day tariff reprieve...
Keep Reading →
April 14 - Hedge Funds, News
Some experts view medical, healthcare, and big pharma stocks as immune from trade carnage, making them a safe haven amid the uncertainty brought about by Trump's tariffs.
Keep Reading →
April 10 - Hedge Funds, Industries, News
Amid growing concerns about economic growth and President Trump's tariffs, investors have been seeking safer investment options.
Keep Reading →
April 9 - Dividend Stocks, Hedge Funds, News
Ken Fisher, an American billionaire investor, author, and financial analyst, founded and runs Fisher Asset Management.
Keep Reading →
April 8 - Hedge Funds, News
On Thursday, April 3rd, the host of Mad Money opened the most recent show by addressing the growing concerns surrounding the current tariff policies.
Keep Reading →
April 7 - Hedge Funds, News
The US stock market has experienced a turbulent first quarter of 2025, marked by increased volatility and negative returns across the major indices.
Keep Reading →
April 6 - Hedge Funds, News
On Wednesday, Jim Cramer, the host of Mad Money, shared his concerns about President Donald Trump's approach to trade and its implications for investors.
Keep Reading →
April 3 - Hedge Funds, News
Jim Cramer in a latest program on CNBC urged investors to start accepting the reality of the new economic system under President Trump and said the new tariffs will result in ...
Keep Reading →
April 3 - Hedge Funds, News
Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases.
Keep Reading →
March 31 - Hedge Funds, News
Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and AI.
Keep Reading →
March 30 - Hedge Funds, News
“Who am I to tell you anything, much less anything that counts? Or that there are only three questions that count and I know what they are? Why should you bother reading any...
Keep Reading →
March 26 - Hedge Funds, News
Billionaire Ken Fisher, a prominent money manager, renowned author, and financial analyst, is the founder of Fisher Asset Management.
Keep Reading →
March 24 - Hedge Funds, News